It is exactly considerations like this that make the DNDN disregard for science more puzzling. Their IT infrastructure, in vitro approach, and need to monitor contamination, LPS is a good case in point, give them the ideal platform from which to sort out these inconsistent results. So, why the interest in video and politics? A few IT guys playing with their clinical monitoring data could probably do quite a bit. Again, there is some hope their new CFO is leading an array based science effort but I won't make any assumptions until I see some evidence ...